Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Our primary objective was to evaluate the causal impact of 25(OH)D and its metabolites, including 25(OH)D3 and its epimer C3-epi-25(OH)D3, on susceptibility to OPC through the use of Mendelian randomization (MR) methodology.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Genetic instrumental-variable study.

Genetic instrumental-variable study

Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.

Meta-analysis reported · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The causal associations of 25(OH)D and its metabolites with oropharyngeal cancer risk: a Mendelian randomization study

Source: Article title.

We screened PubMed for meta-analyses or systematic reviews dated from inception to February 2024 that investigated correlations between exposure to 25(OH)D, C3-epi-25(OH)D3, and 25(OH)D3 and OPC in European, North American, and South American populations.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The causal associations of 25(OH)D and its metabolites with oropharyngeal cancer risk: a Mendelian randomization study

Genetic instrumental-variable study · Acta Odontologica Scandinavica · 2025

Original publication title

The causal associations of 25(OH)D and its metabolites with oropharyngeal cancer risk: a Mendelian randomization study

YaoHui Yu; Yu Zhou

© 2025 The Author(s)

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

There was no evidence that 25(OH)D, 25(OH)D3 or C3-epi-25(OH)D3 levels are associated with OPC risk or that 25OHD supplementation in the general population prevents OPC.

The registration number is INPLASY202490081.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Previous studies have suggested that there are distinct correlations of 25-hydroxyvitamin D (25(OH)D) and its metabolites with the risk of developing health conditions and cancer; however, the precise nature of these associations in patients with oropharyngeal cancer (OPC) is unknown. Our primary objective was to evaluate the causal impact of 25(OH)D and its metabolites, including 25(OH)D3 and its epimer C3-epi-25(OH)D3, on susceptibility to OPC through the use of Mendelian randomization (MR) methodology.

Source: Background

Abstract: What methods does the paper describe?

Mendelian randomization analysis was performed on data from 291 patients with OPC from Europe, North America, and South America using genetic variant strongly related to C3-epi-25(OH)D3, 25(OH)D, and 25(OH)D3 exposure. The primary analytical method for two-sample MR analysis was inverse-variance weighting (IVW); supplemental analyses (weighted median [WM], MR: Egger) were also conducted. Leave-one-out and Cochran’s Q tests were concurrently used as sensitivity analyses to test and adjust for pleiotropy.

Source: Methods

Abstract: Results

Our MR analysis provided evidence suggesting that greater 25(OH)D3 levels are causally associated with a decreased risk of developing OPC within the European population (WM OR = 0.47, 95% CI = 0.24 to 0.91, p = 0.03). Only one of the 21 MR analyses yielded significant results; for this MR analysis, the IVW results were significant, but subsequent leave-one-out analyses revealed instability in the causal association. However, the association was significant when rs9304669 was excluded (OR = 0.51, 95% CI = 0.28 to 0.91, p = 0.02), whereas the other results were not statistically significant.

The sensitivity analysis indicated that the results were reliable, with no observed heterogeneity or pleiotropy.

Source: Results

Abstract: Conclusions

There was no evidence that 25(OH)D, 25(OH)D3 or C3-epi-25(OH)D3 levels are associated with OPC risk or that 25OHD supplementation in the general population prevents OPC.

The registration number is INPLASY202490081.

Source: Conclusions Source: Conclusions
Authors’ abstract

Background

Previous studies have suggested that there are distinct correlations of 25-hydroxyvitamin D (25(OH)D) and its metabolites with the risk of developing health conditions and cancer; however, the precise nature of these associations in patients with oropharyngeal cancer (OPC) is unknown. Our primary objective was to evaluate the causal impact of 25(OH)D and its metabolites, including 25(OH)D3 and its epimer C3-epi-25(OH)D3, on susceptibility to OPC through the use of Mendelian randomization (MR) methodology.

Methods

Mendelian randomization analysis was performed on data from 291 patients with OPC from Europe, North America, and South America using genetic variant strongly related to C3-epi-25(OH)D3, 25(OH)D, and 25(OH)D3 exposure. The primary analytical method for two-sample MR analysis was inverse-variance weighting (IVW); supplemental analyses (weighted median [WM], MR: Egger) were also conducted. Leave-one-out and Cochran’s Q tests were concurrently used as sensitivity analyses to test and adjust for pleiotropy.

Results

Our MR analysis provided evidence suggesting that greater 25(OH)D3 levels are causally associated with a decreased risk of developing OPC within the European population (WM OR = 0.47, 95% CI = 0.24 to 0.91, p = 0.03). Only one of the 21 MR analyses yielded significant results; for this MR analysis, the IVW results were significant, but subsequent leave-one-out analyses revealed instability in the causal association. However, the association was significant when rs9304669 was excluded (OR = 0.51, 95% CI = 0.28 to 0.91, p = 0.02), whereas the other results were not statistically significant.

The sensitivity analysis indicated that the results were reliable, with no observed heterogeneity or pleiotropy.

Conclusions

There was no evidence that 25(OH)D, 25(OH)D3 or C3-epi-25(OH)D3 levels are associated with OPC risk or that 25OHD supplementation in the general population prevents OPC.

The registration number is INPLASY202490081.

Publication and source details

Original title: The causal associations of 25(OH)D and its metabolites with oropharyngeal cancer risk: a Mendelian randomization study

YaoHui Yu; Yu Zhou

Acta Odontologica Scandinavica · 2025

CONTACT Yu Zhou zhouyu@wmu.edu.cn Department of Orthodontics, School and Hospital of Stomatology, Wenzhou Medical University, No. 1288, Longyao Avenue, Yongzhong Subdistrict, Longwan District, Wenzhou, Zhejiang, China

Supplemental data for this article can be accessed online at https://doi.org/10.2340/aos.v84.44053

© 2025 The Author(s)2025https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, with the condition of proper attribution to the original work.Funding The study was supported by Scientific Research Fund of Department of Education of Zhejiang Province (Y202457189).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:25:23.847468+00:00

DOI: 10.2340/aos.v84.44053 · PMC12362939